Zevra Therapeutics (ZVRA) Return on Sales [ROS] (2019 - 2026)
Zevra Therapeutics (ZVRA) posted Return on Sales [ROS] of 30.63% for Q3 2026, up 14.76 percentage points from 15.87% a year earlier but down 11.62 percentage points from the prior quarter.
Zevra Therapeutics (ZVRA) Return on Sales [ROS] (2019 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Return on Sales [ROS] at Zevra Therapeutics was 60.74%, up 164.60 percentage points year-over-year; for FY2025, it came in at -59.10%, up 309.37 percentage points from FY2024.
- Annual Return on Sales [ROS] shows a five-year change of -16.89 percentage points (FY2020 to FY2025).
- In prior years, Zevra Therapeutics' Return on Sales [ROS] was -368.47% in FY2024 (-187.84 pp), -180.63% in FY2023 (+238.27 pp), -418.91% in FY2022 (-445.88 pp) and 26.98% in FY2021 (+69.19 pp).
- Quarterly Return on Sales [ROS] has run from a low of -1905.15% in Q2 2022 to a high of 143.97% in Q1 2026 over five years.
- On a year-over-year basis, Return on Sales [ROS] has increased in each of the last seven quarters, with an average year-over-year change of +279.05 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q2 2023, with a gain of 1831.34 percentage points; the weakest was Q2 2022, with a drop of 1953.82 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was 42.26% (Q2 2026), 143.97% (Q1 2026) and 27.27% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn | 30.63% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 30.63% |
| Jun 30, 2026 | 42.26% |
| Mar 31, 2026 | 143.97% |
| Dec 31, 2025 | 27.27% |
| Sep 30, 2025 | 15.87% |
| Jun 30, 2025 | -274.28% |
| Mar 31, 2025 | -26.28% |
| Dec 31, 2024 | -128.34% |
| Sep 30, 2024 | -738.00% |
| Jun 30, 2024 | -534.84% |
| Mar 31, 2024 | -598.13% |
| Dec 31, 2023 | -117.31% |
| Sep 30, 2023 | -530.71% |
| Jun 30, 2023 | -73.81% |
| Mar 31, 2023 | -404.00% |
| Dec 31, 2022 | -460.58% |
| Sep 30, 2022 | -230.55% |
| Jun 30, 2022 | -1,905.15% |
| Mar 31, 2022 | -46.89% |
| Dec 31, 2021 | -110.07% |
Zevra Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();